Biden: 250,000 treatment courses of Pfizer anti-viral due in January

1 minute read

U.S. President Joe Biden meets with his Supply Chain Disruptions Task Force and private sector CEOs at the White House in Washington, U.S. December 22, 2021. REUTERS/Kevin Lamarque     

Register now for FREE unlimited access to Reuters.com

Dec 22 (Reuters) - U.S. President Joe Biden said on Wednesday that 250,000 treatment courses of Pfizer's newly authorized COVID-19 anti-viral drug will be available in January from the 10 million courses the United States had pre-purchased.

Biden said in a statement that his administration would work with states to ensure the treatments are distributed equitably and that hardest-hit communities are reached.

Register now for FREE unlimited access to Reuters.com
Reporting by Paul Grant; Editing by Tim Ahmann

Our Standards: The Thomson Reuters Trust Principles.